Skip to main content

Articles

Page 38 of 38

  1. Multiple neurodegenerative diseases are characterized by the abnormal accumulation of FUS protein including various subtypes of frontotemporal lobar degeneration with FUS inclusions (FTLD-FUS). These subtypes ...

    Authors: Edward B Lee, Jenny Russ, Hyunjoo Jung, Lauren B Elman, Lama M Chahine, Daniel Kremens, Bruce L Miller, H Branch Coslett, John Q Trojanowski, Vivianna M Van Deerlin and Leo F McCluskey
    Citation: Acta Neuropathologica Communications 2013 1:9
    Content type: Research Published on:

  2. Neuron Glial 2 (NG2) cells are glial cells known to serve as oligodendrocyte progenitors as well as modulators of the neuronal network. Altered NG2 cell morphology and up-regulation as well as increased sheddi...

    Authors: Henrietta M Nielsen, Danyal Ek, Una Avdic, Camilla Orbjörn, Oskar Hansson, Robert Veerhuis, Annemieke JM Rozemuller, Arne Brun, Lennart Minthon and Malin Wennström
    Citation: Acta Neuropathologica Communications 2013 1:7
    Content type: Research Published on:

  3. Neuromyelitis optica (NMO) is a severe, disabling disease of the central nervous system (CNS) characterized by the formation of astrocyte-destructive, neutrophil-dominated inflammatory lesions in the spinal co...

    Authors: Maja Kitic, Sonja Hochmeister, Isabella Wimmer, Jan Bauer, Tatsuro Misu, Simone Mader, Markus Reindl, Kazuo Fujihara, Hans Lassmann and Monika Bradl
    Citation: Acta Neuropathologica Communications 2013 1:5
    Content type: Research Published on:

  4. To investigate the association of DNA nucleotide excision repair (NER) defects with neurological degeneration, cachexia and cancer, we performed autopsies on 4 adult xeroderma pigmentosum (XP) patients with di...

    Authors: Jin-Ping Lai, Yen-Chun Liu, Meghna Alimchandani, Qingyan Liu, Phyu Phyu Aung, Kant Matsuda, Chyi-Chia R Lee, Maria Tsokos, Stephen Hewitt, Elisabeth J Rushing, Deborah Tamura, David L Levens, John J DiGiovanna, Howard A Fine, Nicholas Patronas, Sikandar G Khan…
    Citation: Acta Neuropathologica Communications 2013 1:4
    Content type: Research Published on:

  5. The development of disease-modifying therapies for Alzheimer’s disease is hampered by our lack of understanding of the early pathogenic mechanisms and the lack of early biomarkers and risk factors.

    Authors: Sharon C Yates, Amen Zafar, Paul Hubbard, Sheila Nagy, Sarah Durant, Roy Bicknell, Gordon Wilcock, Sharon Christie, Margaret M Esiri, A David Smith and Zsuzsanna Nagy
    Citation: Acta Neuropathologica Communications 2013 1:3
    Content type: Research Published on:

  6. Parkinson’s disease (PD) is a progressive neurodegenerative disorder typified by the presence of intraneuronal inclusions containing aggregated alpha synuclein (αsyn). The progression of parkinsonian pathology...

    Authors: Naomi P Visanji, Patricia L Brooks, Lili-Naz Hazrati and Anthony E Lang
    Citation: Acta Neuropathologica Communications 2013 1:2
    Content type: Review Published on:
Logo
Submit manuscript

Follow

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 6.2
    5-year Journal Impact Factor: 6.8
    Source Normalized Impact per Paper (SNIP): 1.344
    SCImago Journal Rank (SJR): 2.580

    Speed 2023
    Submission to first editorial decision (median days): 3
    Submission to acceptance (median days): 50

    Usage 2023
    Downloads: 1,631,164
    Altmetric mentions: 3,652

Acta Neuropathologica Communications

ISSN: 2051-5960

Contact us